• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调强放射治疗:优势、局限性及未来发展

Intensity modulated radiotherapy: advantages, limitations and future developments.

作者信息

Cheung Ky

机构信息

Department of Clinical Oncology, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.

出版信息

Biomed Imaging Interv J. 2006 Jan;2(1):e19. doi: 10.2349/biij.2.1.e19. Epub 2006 Jan 1.

DOI:10.2349/biij.2.1.e19
PMID:21614217
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3097603/
Abstract

Intensity modulated radiotherapy (IMRT) is widely used in clinical applications in developed countries, for the treatment of malignant and non-malignant diseases. This technique uses multiple radiation beams of non-uniform intensities. The beams are modulated to the required intensity maps for delivering highly conformal doses of radiation to the treatment targets, while sparing the adjacent normal tissue structures. This treatment technique has superior dosimetric advantages over 2-dimensional (2D) and conventional 3-dimensional conformal radiotherapy (3DCRT) treatments. It can potentially benefit the patient in three ways. First, by improving conformity with target dose it can reduce the probability of in-field recurrence. Second, by reducing irradiation of normal tissue it can minimise the degree of morbidity associated with treatment. Third, by facilitating escalation of dose it can improve local control. Early clinical results are promising, particularly in the treatment of nasopharyngeal carcinoma (NPC). However, as the IMRT is a sophisticated treatment involving high conformity and high precision, it has specific requirements. Therefore, tight tolerance levels for random and systematic errors, compared with conventional 2D and 3D treatments, must be applied in all treatment and pre-treatment procedures. For this reason, a large-scale routine clinical implementation of the treatment modality demands major resources and, in some cases, is impractical. This paper will provide an overview of the potential advantages of the IMRT, methods of treatment delivery, and equipment currently available for facilitating the treatment modality. It will also discuss the limitations of the equipment and the ongoing development work to improve the efficiency of the equipment and the treatment techniques and procedures.

摘要

调强放射治疗(IMRT)在发达国家的临床应用中被广泛用于治疗恶性和非恶性疾病。该技术使用强度不均匀的多个辐射束。这些束被调制为所需的强度分布图,以便向治疗靶区提供高度适形的辐射剂量,同时 sparing 相邻的正常组织结构。这种治疗技术比二维(2D)和传统三维适形放射治疗(3DCRT)具有更好的剂量学优势。它可能在三个方面使患者受益。首先,通过提高与靶剂量的适形性,它可以降低靶区内复发的概率。其次,通过减少对正常组织的照射,它可以将与治疗相关的发病程度降至最低。第三,通过促进剂量递增,它可以提高局部控制率。早期临床结果很有前景,特别是在鼻咽癌(NPC)的治疗中。然而,由于IMRT是一种涉及高适形性和高精度的复杂治疗方法,它有特定的要求。因此,与传统的2D和3D治疗相比,在所有治疗和预处理程序中必须应用对随机和系统误差的严格容忍水平。出于这个原因,该治疗方式的大规模常规临床实施需要大量资源,并且在某些情况下是不切实际的。本文将概述IMRT的潜在优势、治疗实施方法以及目前可用于促进该治疗方式的设备。它还将讨论设备的局限性以及为提高设备效率和治疗技术及程序而正在进行的开发工作。 (注:文中 sparing 一词未准确译出合适中文,暂保留英文)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/5c34222088ba/biij-02-e19-g19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/7d6299e9bd57/biij-02-e19-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/67f590101f1b/biij-02-e19-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/a5d1b233e377/biij-02-e19-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/57ae542f3219/biij-02-e19-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/62351696bdbe/biij-02-e19-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/d0fd711be1bf/biij-02-e19-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/6a141460eb1d/biij-02-e19-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/7b58c6867a26/biij-02-e19-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/20ba48eb99bb/biij-02-e19-g09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/363008b29829/biij-02-e19-g10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/152aa6c50012/biij-02-e19-g11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/9ff977e71437/biij-02-e19-g12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/e43a0fd6f4cb/biij-02-e19-g13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/9830231d2f3d/biij-02-e19-g14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/f69a306c640a/biij-02-e19-g15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/f29e9a7de13a/biij-02-e19-g16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/126e05c005b3/biij-02-e19-g17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/e2d4c62fed76/biij-02-e19-g18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/5c34222088ba/biij-02-e19-g19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/7d6299e9bd57/biij-02-e19-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/67f590101f1b/biij-02-e19-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/a5d1b233e377/biij-02-e19-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/57ae542f3219/biij-02-e19-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/62351696bdbe/biij-02-e19-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/d0fd711be1bf/biij-02-e19-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/6a141460eb1d/biij-02-e19-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/7b58c6867a26/biij-02-e19-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/20ba48eb99bb/biij-02-e19-g09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/363008b29829/biij-02-e19-g10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/152aa6c50012/biij-02-e19-g11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/9ff977e71437/biij-02-e19-g12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/e43a0fd6f4cb/biij-02-e19-g13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/9830231d2f3d/biij-02-e19-g14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/f69a306c640a/biij-02-e19-g15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/f29e9a7de13a/biij-02-e19-g16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/126e05c005b3/biij-02-e19-g17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/e2d4c62fed76/biij-02-e19-g18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d48/3097603/5c34222088ba/biij-02-e19-g19.jpg

相似文献

1
Intensity modulated radiotherapy: advantages, limitations and future developments.调强放射治疗:优势、局限性及未来发展
Biomed Imaging Interv J. 2006 Jan;2(1):e19. doi: 10.2349/biij.2.1.e19. Epub 2006 Jan 1.
2
Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.鼻咽癌调强放射治疗:与传统计划相比的剂量学优势及剂量递增的可行性
Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):145-57. doi: 10.1016/s0360-3016(03)00075-0.
3
The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study.头颈部癌调强放射治疗中腮腺保留及生物等效剂量增加的潜力:一项治疗设计研究。
Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):195-205. doi: 10.1016/s0360-3016(99)00304-1.
4
Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensity-modulated techniques.腮腺癌放射治疗的优化:传统、三维适形和调强技术的比较
Radiother Oncol. 2001 Aug;60(2):163-72. doi: 10.1016/s0167-8140(01)00339-5.
5
Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.基于一维和二维调强放射治疗的凹形计划靶区治疗的逆向和正向优化:以前列腺癌为例
Radiother Oncol. 2003 Feb;66(2):185-95. doi: 10.1016/s0167-8140(02)00375-4.
6
Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.不可切除的非小细胞肺癌治疗中降低毒性和增加剂量的潜力:调强放射治疗(IMRT)、三维适形放疗和选择性淋巴结照射的比较
Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):875-90. doi: 10.1016/s0360-3016(03)00743-0.
7
Dose planning study of target volume coverage with intensity- modulated radiotherapy for nasopharyngeal carcinoma: Penang General Hospital experience.鼻咽癌调强放射治疗靶区覆盖的剂量规划研究:槟城总医院经验
Asian Pac J Cancer Prev. 2013;14(4):2243-8. doi: 10.7314/apjcp.2013.14.4.2243.
8
Critical appraisal of treatment techniques based on conventional photon beams, intensity modulated photon beams and proton beams for therapy of intact breast.基于传统光子束、调强光子束和质子束的完整乳腺治疗技术的批判性评估。
Radiother Oncol. 2002 Feb;62(2):137-45. doi: 10.1016/s0167-8140(01)00476-5.
9
Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer.采用自适应放疗联合三维适形或调强射束技术对前列腺癌进行剂量递增的改进。
Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1226-34. doi: 10.1016/s0360-3016(01)01552-8.
10
Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.二维放射治疗与调强放射治疗在晚期T 期鼻咽癌治疗中的剂量学比较:在脑干和脊髓的计划危及器官体积中是少照射还是多照射。
Med Dosim. 2007 Winter;32(4):263-70. doi: 10.1016/j.meddos.2007.02.006.

引用本文的文献

1
Prediction of Radiation Therapy Induced Cardiovascular Toxicity from Pretreatment CT Images in Patients with Thoracic Malignancy via an Optimal Biomarker Approach.通过优化生物标志物方法,利用胸部恶性肿瘤患者治疗前CT图像预测放射治疗诱发的心血管毒性
Acad Radiol. 2025 Apr;32(4):1895-1905. doi: 10.1016/j.acra.2025.01.012. Epub 2025 Jan 26.
2
Synthesizing Efficiency Tools in Radiotherapy to Increase Patient Flow: A Comprehensive Literature Review.综合放疗中的效率工具以增加患者流量:一项全面的文献综述。
Clin Med Insights Oncol. 2024 Dec 13;18:11795549241303606. doi: 10.1177/11795549241303606. eCollection 2024.
3

本文引用的文献

1
Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome.调强放射治疗对外阴癌的治疗:一项剂量学比较研究及早期临床结果
Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1395-400. doi: 10.1016/j.ijrobp.2005.11.007. Epub 2006 Jan 25.
2
Positron emission tomography for target volume definition in the treatment of non-small cell lung cancer.
Radiother Oncol. 2005 Oct;77(1):1-4. doi: 10.1016/j.radonc.2005.09.016. Epub 2005 Oct 12.
3
Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma.局部晚期鼻咽癌放射剂量递增的初步结果。
Assessing Radiology and Radiation Therapy Needs for Cancer Care in Low-and-Middle-Income Countries: Insight From a Global Survey of Departmental and Institutional Leaders.
评估低收入和中等收入国家癌症治疗的放射学和放射治疗需求:来自部门和机构领导者全球调查的见解
Adv Radiat Oncol. 2024 Aug 29;9(11):101615. doi: 10.1016/j.adro.2024.101615. eCollection 2024 Nov.
4
Revolutionizing Brain Tumor Care: Emerging Technologies and Strategies.变革脑肿瘤护理:新兴技术与策略
Biomedicines. 2024 Jun 20;12(6):1376. doi: 10.3390/biomedicines12061376.
5
A retrospective study on the delay in three different timescales of CT simulation among patients with pediatric cancer in a tertiary hospital.一项关于某三级医院儿科癌症患者CT模拟三个不同时间尺度延迟情况的回顾性研究。
Oncol Lett. 2024 Apr 18;27(6):272. doi: 10.3892/ol.2024.14405. eCollection 2024 Jun.
6
Comparison of commercial atlas-based automatic segmentation software for prostate radiotherapy treatment planning.商业图谱自动分割软件在前列腺放射治疗计划中的比较。
Phys Eng Sci Med. 2024 Sep;47(3):881-894. doi: 10.1007/s13246-024-01411-2. Epub 2024 Apr 22.
7
Emerging Trends of Nanomedicines in the Management of Prostate Cancer: Perspectives and Potential Applications.纳米药物在前列腺癌治疗中的新兴趋势:观点与潜在应用
Pharmaceutics. 2024 Feb 20;16(3):297. doi: 10.3390/pharmaceutics16030297.
8
Single-Pulse X-ray Acoustic Computed Tomographic Imaging for Precision Radiation Therapy.用于精确放射治疗的单脉冲X射线声学计算机断层成像
Adv Radiat Oncol. 2023 Apr 14;8(4):101239. doi: 10.1016/j.adro.2023.101239. eCollection 2023 Jul-Aug.
9
Longitudinal functional outcomes and late effects of radiation following treatment of nasopharyngeal carcinoma: secondary analysis of a prospective cohort study.鼻咽癌治疗后纵向功能结局和晚期放射效应:前瞻性队列研究的二次分析。
J Otolaryngol Head Neck Surg. 2022 Nov 8;51(1):41. doi: 10.1186/s40463-022-00593-7.
10
The Impact of Temporal Changes in Irradiated nMAG Polymer Gels on Their Applicability in Small Field Dosimetry in Radiotherapy.辐照nMAG聚合物凝胶的时间变化对其在放射治疗小场剂量测定中适用性的影响
Gels. 2022 Oct 4;8(10):629. doi: 10.3390/gels8100629.
Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):374-81. doi: 10.1016/j.ijrobp.2005.07.968. Epub 2005 Oct 5.
4
Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome.调强放射治疗(IMRT)在肛管癌治疗中的应用:毒性反应及临床疗效
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):354-61. doi: 10.1016/j.ijrobp.2005.02.030.
5
Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study.
Radiother Oncol. 2005 Oct;77(1):5-10. doi: 10.1016/j.radonc.2005.06.014. Epub 2005 Jul 12.
6
Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.调强放射治疗在口咽癌治疗中的应用:纪念斯隆凯特琳癌症中心的经验
Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):363-73. doi: 10.1016/j.ijrobp.2005.03.006. Epub 2005 May 31.
7
Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy.使用三维适形放疗和调强放疗对前列腺癌进行全盆腔放疗。
Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):765-71. doi: 10.1016/j.ijrobp.2005.02.050.
8
Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes.使用变形强度分布对图像引导的调强放射治疗进行在线修正,以考虑分次间的解剖结构变化。
Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1258-66. doi: 10.1016/j.ijrobp.2004.11.033.
9
Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.调强放射治疗鼻咽癌:香港的经验
Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1440-50. doi: 10.1016/j.ijrobp.2004.05.022.
10
Radiotherapy for nasopharyngeal carcinoma--transition from two-dimensional to three-dimensional methods.鼻咽癌的放射治疗——从二维方法向三维方法的转变。
Radiother Oncol. 2004 Nov;73(2):163-72. doi: 10.1016/j.radonc.2004.06.005.